amrinone has been researched along with Arrhythmia in 17 studies
Amrinone: A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
amrinone : A 3,4'-bipyridine substituted at positions 5 and 6 by an amino group and a keto function respectively. A pyridine phosphodiesterase 3 inhibitor, it is a drug that may improve the prognosis in patients with congestive heart failure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The use of amrinone, a cardiac inotropic agent with vasodilatory properties, has not been described in human pregnancy." | 7.68 | Use of intravenous amrinone in the short-term management of refractory heart failure in pregnancy. ( Bhatia, RK; Ganguly, S; Jelsema, RD, 1991) |
| "Amrinone, a new inotropic agent, was used to treat 24 patients with chronic congestive heart failure who were classified as clinically stable and who were in New York Heart Association's classes II and III." | 7.67 | Clinical effects and side effects of amrinone. A study of 24 patients with chronic congestive heart failure. ( Gerber, L; Merrill, AJ; Silverman, BD, 1985) |
| "Clinical trials of intravenous amrinone were performed in 462 patients severely ill with congestive heart failure." | 5.05 | Clinical safety of intravenous amrinone--a review. ( Treadway, G, 1985) |
| "5-2% sevoflurane anesthesia, 0." | 3.69 | Amrinone is superior to epinephrine in reversing bupivacaine-induced cardiovascular depression in sevoflurane-anesthetized dogs. ( Fukuda, H; Hirabayashi, Y; Saitoh, K; Shimizu, R, 1995) |
| "The use of amrinone, a cardiac inotropic agent with vasodilatory properties, has not been described in human pregnancy." | 3.68 | Use of intravenous amrinone in the short-term management of refractory heart failure in pregnancy. ( Bhatia, RK; Ganguly, S; Jelsema, RD, 1991) |
| " Attempts to support cardiovascular function by high-dose dobutamine infusions were complicated by life-threatening cardiac arrhythmias." | 3.67 | Augmentation of cardiac function in end-stage heart failure by combined use of dobutamine and amrinone. ( Guimond, JG; Keating, D; Matuschak, GM; Meyers, F, 1986) |
| "Amrinone, a new inotropic agent, was used to treat 24 patients with chronic congestive heart failure who were classified as clinically stable and who were in New York Heart Association's classes II and III." | 3.67 | Clinical effects and side effects of amrinone. A study of 24 patients with chronic congestive heart failure. ( Gerber, L; Merrill, AJ; Silverman, BD, 1985) |
| "Significant proarrhythmia is uncommon, but can occur." | 1.28 | Electrophysiology of phosphodiesterase inhibitors. ( Goldstein, RA; Naccarelli, GV, 1989) |
| "Dobutamine and amrinone were much better tolerated." | 1.27 | Comparative vasoactive therapy for heart failure. ( Alpert, JS; Benotti, JR; McCue, JE, 1985) |
| "Patients with congestive heart failure (CHF) have a high prevalence of complex ventricular arrhythmias." | 1.27 | Electrophysiologic effects of amrinone. ( Dougherty, AH; Goldstein, RA; Gray, EL; Naccarelli, GV, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (64.71) | 18.7374 |
| 1990's | 4 (23.53) | 18.2507 |
| 2000's | 1 (5.88) | 29.6817 |
| 2010's | 1 (5.88) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, Y | 1 |
| Yuan, J | 1 |
| Qian, Z | 1 |
| Zhang, X | 1 |
| Chen, Y | 1 |
| Hou, X | 1 |
| Zou, J | 1 |
| Ko, Y | 1 |
| Morita, K | 1 |
| Nagahori, R | 1 |
| Kinouchi, K | 1 |
| Shinohara, G | 1 |
| Kagawa, H | 1 |
| Hashimoto, K | 1 |
| Méndez, R | 1 |
| Onuaguluchi, G | 2 |
| Tanz, RD | 2 |
| McCawley, E | 1 |
| Saitoh, K | 1 |
| Hirabayashi, Y | 1 |
| Shimizu, R | 1 |
| Fukuda, H | 1 |
| Trolese-Mongheal, Y | 1 |
| Barthelemy, J | 1 |
| Paire, M | 1 |
| Duchene-Marullaz, P | 1 |
| Jelsema, RD | 1 |
| Bhatia, RK | 1 |
| Ganguly, S | 1 |
| Xu, D | 1 |
| Yang, Z | 1 |
| Naccarelli, GV | 3 |
| Goldstein, RA | 3 |
| Tommaso, CL | 1 |
| Guimond, JG | 1 |
| Matuschak, GM | 1 |
| Meyers, F | 1 |
| Keating, D | 1 |
| Treadway, G | 1 |
| Silverman, BD | 1 |
| Merrill, AJ | 1 |
| Gerber, L | 1 |
| Benotti, JR | 1 |
| McCue, JE | 1 |
| Alpert, JS | 1 |
| Gray, EL | 1 |
| Dougherty, AH | 1 |
2 reviews available for amrinone and Arrhythmia
| Article | Year |
|---|---|
[The old digitalis and the new cardiac inotropic agents].
Topics: Aminopyridines; Amrinone; Arrhythmias, Cardiac; Cardenolides; Cardiotonic Agents; Digitalis Glycosid | 1983 |
Non-glycoside, non-catecholamine inotropic agents in the treatment of congestive heart failure.
Topics: Administration, Oral; Aminopyridines; Amrinone; Arrhythmias, Cardiac; Calcium; Cardiac Output; Cardi | 1986 |
1 trial available for amrinone and Arrhythmia
| Article | Year |
|---|---|
Clinical safety of intravenous amrinone--a review.
Topics: Aminopyridines; Amrinone; Arrhythmias, Cardiac; Cardiotonic Agents; Clinical Trials as Topic; Drug I | 1985 |
14 other studies available for amrinone and Arrhythmia
| Article | Year |
|---|---|
β2 adrenergic receptor activation governs cardiac repolarization and arrhythmogenesis in a guinea pig model of heart failure.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Amrinone; Animals; Arrhythmias, Ca | 2015 |
Myocardial cyclic AMP augmentation with high-dose PDEIII inhibitor in terminal warm blood cardioplegia.
Topics: Amrinone; Animals; Arrhythmias, Cardiac; Cardiopulmonary Bypass; Cardiotonic Agents; Coronary Circul | 2009 |
Electromechanical dissociation and possible uncoupling of phosphorylation following tachydysrhythmogenic dose of amrinone in the guinea-pig Langendorff heart preparation.
Topics: Aminopyridines; Amrinone; Animals; Arrhythmias, Cardiac; Cardiotonic Agents; Electrocardiography; Gu | 1984 |
Electrocardiographic changes induced by amrinone in the isolated perfused guinea-pig Langendorff heart preparation.
Topics: Aminopyridines; Amrinone; Animals; Arrhythmias, Cardiac; Cardiotonic Agents; Electrocardiography; Gu | 1983 |
Amrinone is superior to epinephrine in reversing bupivacaine-induced cardiovascular depression in sevoflurane-anesthetized dogs.
Topics: Amrinone; Anesthesia; Anesthetics; Animals; Arrhythmias, Cardiac; Bupivacaine; Dogs; Epinephrine; Et | 1995 |
Arrhythmogenic potencies of amrinone and milrinone in unanesthetized dogs with myocardial infarct.
Topics: Amrinone; Analysis of Variance; Animals; Arrhythmias, Cardiac; Cardiotonic Agents; Dogs; Heart Rate; | 1992 |
Use of intravenous amrinone in the short-term management of refractory heart failure in pregnancy.
Topics: Acidosis, Lactic; Adult; Amrinone; Arrhythmias, Cardiac; Endocarditis, Bacterial; Female; Heart Fail | 1991 |
[The effect of China-made amrinone on myocardial infarction and arrhythmia in dogs].
Topics: Amrinone; Animals; Arrhythmias, Cardiac; Dogs; Myocardial Contraction; Myocardial Infarction; Stimul | 1990 |
Electrophysiology of phosphodiesterase inhibitors.
Topics: Amrinone; Arrhythmias, Cardiac; Cardiotonic Agents; Electrocardiography; Electrophysiology; Heart Co | 1989 |
Augmentation of cardiac function in end-stage heart failure by combined use of dobutamine and amrinone.
Topics: Aminopyridines; Amrinone; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Cardiotonic Agents; Dobutam | 1986 |
Clinical effects and side effects of amrinone. A study of 24 patients with chronic congestive heart failure.
Topics: Adult; Aged; Aminopyridines; Amrinone; Arrhythmias, Cardiac; Cardiotonic Agents; Chronic Disease; El | 1985 |
Comparative vasoactive therapy for heart failure.
Topics: Adult; Aged; Aminopyridines; Amrinone; Arrhythmias, Cardiac; Blood Pressure; Cardiac Output; Cardiot | 1985 |
Electrophysiologic effects of amrinone.
Topics: Adult; Aged; Aminopyridines; Amrinone; Arrhythmias, Cardiac; Cardiac Output; Cardiac Pacing, Artific | 1985 |
Intravenous amrinone.
Topics: Aminopyridines; Amrinone; Arrhythmias, Cardiac; Cardiotonic Agents; Humans; Infusions, Parenteral | 1985 |